Richard Jaenisch explains what FDA's real-world use case database means for CMC and quality teams navigating NAMs.
|Articles|September 25, 2014
Best Practices for Overcoming Softgel Coating Challenges
Author(s)BASF
Best Practices for Overcoming Softgel Coating Challenges
Best Practices for Overcoming Softgel Coating Challenges
A webinar, Best Practices for Overcoming Softgel Coating Challenges, sponsored by BASF and Pharmaceutical Technology magazine, describes advantages of the drug dosage form, solubility issues, and fill selection criteria for moisture regulation and gelatin compatibility. Rita Peters, editorial director of PharmTech, joins Kai Zhuang, Senior Technical Sales Representative, BASF, to share some key points from the presentation.
Upcoming webcast
October :
Related to this article
Boyang Wang, Immortal Dragons, explains how FDA’s Expedited IND Pilot and research partners could speed serial steps to first-in-human trials compared to China’s 818 Decree.
This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating manufacturing systems, centralized data management, Industrial Internet of Things connectivity, electronic batch production records, and AI-driven analytics.
PharmTech AI Pulse Check panelists explain why attribution, audit trails, and sign-off matter more than AI watermark detection for GxP quality teams.
Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
The FDA approves oral pritelivir for drug-resistant herpes sores in immunocompromised patients; what it means for antiviral development and manufacturing.
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
What the Olanzapine Depot Approval Means for CMC Teams
3
Q&A: Patient-Centric Drug Development Should Start at Product Definition
4
PharmTech Weekly Roundup—Oct. 8, 2026: CPHI Highlights
5